Kodiak Sciences Aktie
WKN DE: A2N6P0 / ISIN: US50015M1099
|
29.09.2026 04:38:49
|
Why Kodiak Sciences Skyrocketed Today
Shares of Kodiak Sciences (NASDAQ: KOD) soared 178% on Monday after the eye medicine developer announced positive clinical trial results for two of its leading investigational drug candidates.
Image source: Getty Images.
Kodiak said Zenkuda and KSI-501 met their primary endpoints in a Phase 3 clinical study in patients with wet age-related macular degeneration, a serious eye condition in which abnormal blood vessels grow beneath the retina and leak fluid, which can lead to rapid vision loss.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Kodiak Sciences Inc Registered Shs
| Keine Nachrichten verfügbar. |
Analysen zu Kodiak Sciences Inc Registered Shs
Aktien in diesem Artikel
| Kodiak Sciences Inc Registered Shs | 82,46 | 190,15% |
|